Hostname: page-component-76fb5796d-5g6vh Total loading time: 0 Render date: 2024-04-26T00:40:06.771Z Has data issue: false hasContentIssue false

Urinary Tribulin Output in Patients with Panic Attacks

Published online by Cambridge University Press:  02 January 2018

Trevor R. Norman
Affiliation:
Austin Hospital, Heidelberg, Victoria 3084, Australia
Annick Acevedo
Affiliation:
Austin Hospital, Heidelberg, Victoria 3084, Australia
Graham D. Burrows
Affiliation:
Austin Hospital, Heidelberg, Victoria 3084, Australia
Fiona K. Judd
Affiliation:
Austin Hospital, Heidelberg, Victoria 3084, Australia
Iain M. McIntyre
Affiliation:
Austin Hospital, Heidelberg, Victoria 3084, Australia
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1988 

References

Bhattacharya, S. K., Glover, V., Sandler, M., Clow, A., Topham, A., Bernadt, M. & Murray, R. (1982) Raised endogenous monoamine oxidase inhibitor output in post-withdrawal alcoholics: effects of L-dopa and cthanol. Biological Psychiatry, 17, 826839.Google Scholar
Elsworth, J. D., Dewar, D., Glover, V., Goodwin, B. L., Clow, A. & Sandler, M. (1986) Purification and characterisation of tribulin, an endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding. Journal of Neural Transmission, 67, 4556.Google Scholar
Petursson, H., Bhattacharya, S. K., Glover, V., Sandler, M. and Lader, M. H. (1982) Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. British Journal of Psychiatry, 140, 710.CrossRefGoogle ScholarPubMed
Sandler, M. (1982) The emergence of tribulin. Trends in Pharmacological Sciences, 3, 471472.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.